Sun Pharma Outlook for the Week (Apr 16, 2018 – Apr 20, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Apr 16, 2018 – Apr 20, 2018) : SUN PHARMA: SUN PHARMA closed the week on absolutely flat note....
Tag : sun pharma
Sun Pharma Outlook for the Week (Apr 09, 2018 – Apr 13, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Apr 09, 2018 – Apr 13, 2018) : SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
Sun Pharma Outlook for the Week (Apr 02, 2018 – Apr 06, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Apr 02, 2018 – Apr 06, 2018) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Outlook for the Week (Mar 26, 2018 – Mar 28, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Mar 26, 2018 – Mar 28, 2018) : SUN PHARMA: SUN PHARMA closed the week on absolutely flat note....
Sun Pharma gets USFDA nod for psoriasis drug Ilumya
Sun Pharmaceuticals Industries has received approval from USFDA, for its psoriasis drug Ilumya. Ilumya is generically known as tildrakizumab-asmn and comes under specialty drugs –...
Sun Pharma Outlook for the Week (Mar 12, 2018 – Mar 16, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Mar 12, 2018 – Mar 16, 2018) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Outlook for the Week (Mar 05, 2018 – Mar 09, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Mar 05, 2018 – Mar 09, 2018) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Outlook for the Week (Feb 26, 2018 – Mar 02, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Feb 26, 2018 – Mar 02, 2018) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Outlook for the Week (Feb 19, 2018 – Feb 23, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Feb 19, 2018 – Feb 23, 2018) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Q3 profit declines 75% to Rs.365 crore
Sun Pharma has reported 75.2% decline in the profit for the quarter ended December 31,2017, at Rs.365.4 crore. Profit for the corresponding quarter in the...